Brand name
Veppanu, the original
We didn’t find a savings card or cash price from Veppanu’s maker. Ask the pharmacy for Veppanu’s cash price. With insurance, ask what your plan charges.
Generic name: vepdegestrant
Used for: Advanced ER+, HER2- breast cancer with an ESR1 mutation
Ask for the cash price
Veppanu
We didn’t find one.
Veppanu, the original
We didn’t find a savings card or cash price from Veppanu’s maker. Ask the pharmacy for Veppanu’s cash price. With insurance, ask what your plan charges.
There isn’t one.
We didn’t find one.
VEPPANU is a heterobifunctional protein degrader indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.
Source: the FDA label for Veppanu (Rigel Pharmaceuticals, Inc.), June 12, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/veppanu/